Magnetic Resonance Imaging and Spectroscopy at High Field
This study has been withdrawn prior to enrollment.
Information provided by (Responsible Party):
Min-Ying (Lydia) Su, University of California, Irvine
First received: January 12, 2008
Last updated: June 19, 2013
Last verified: June 2013
Evaluating novel MR imaging techniques on volunteers.
Device: Magnetic Resonance Imaging
||Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Basic Science
||Magnetic Resonance Imaging and Spectroscopy at High Field
Primary Outcome Measures:
- General purpose novel magnetic resonance imaging contrasts, developments for improved magnetic resonance image quality [ Time Frame: 10 years ] [ Designated as safety issue: No ]
| Study Start Date:
| Estimated Primary Completion Date:
||July 2012 (Final data collection date for primary outcome measure)
Device: Magnetic Resonance Imaging
Some participants may receive MRI contrast agent, 0.1 mmol/kg
The aim of this study is twofold. The first aim is to evaluate new MRI techniques developed by the investigators of this protocol on human volunteers. The second aim is to assist other investigators who need to use MR images obtained on this device for their own research. MR images and/or spectroscopy data will be acquired from the participants in this protocol.
|Ages Eligible for Study:
||18 Years to 90 Years
|Genders Eligible for Study:
|Accepts Healthy Volunteers:
- Healthy normal volunteers for imaging protocol optimization.
- Patients with implanted surgical clips (hemostatic clips) or other ferromagnetic material,
- Patients engaged in occupations or activities which may cause accidental lodging of ferromagnetic materials, or who may have imbedded metal fragments from military activities,
- Patients with permanent (tattoo) eye-liner or with facial make-up (severe eye irritation has been reported),
- Patients with compromised thermoregulatory systems (e.g. certain cancer patients),
- Patients with metallic implants, because they may cause artifacts in diagnostic images due to magnetic field distortion,
- Patients with implanted prosthetic heart valves,
- Patients with pacemakers, neuro-stimulation devices,
- Pregnant patients (the safety of magnetic resonance examination has not been completely established for embryos and fetuses),
- Subjects who have received orthodontic work involving ferromagnetic materials,
- Subjects who have claustrophobia, and
- The patients unwilling to participate in the study or fail to sign the consent form.
- Subjects who are pregnant or breast-feeding will be excluded from the contrast enhanced MRI studies.
- Subjects who had allergic response to contrast agents previously will be excluded from contrast enhanced MRI studies.
- Subjects with known history of asthma, allergic conditions, severe renal insufficiency, sickle cell anemia, chronic hemolytic anemia, gastrointestinal disorders will also be excluded from contrast enhanced MRI studies.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00611013
|Center for Functional Onco-Imaging, University of California
|Irvine, California, United States, 92697 |
University of California, Irvine
||Lutfi T Muftuler, Ph.D.
||University of California, Irvine
No publications provided
||Min-Ying (Lydia) Su, Professor, University of California, Irvine
History of Changes
|Other Study ID Numbers:
|Study First Received:
||January 12, 2008
||June 19, 2013
||United States: Institutional Review Board
Keywords provided by University of California, Irvine:
ClinicalTrials.gov processed this record on November 19, 2014
Development of multi-purpose novel imaging protocols